Tempol protects against ischemic acute renal failure by inhibiting renal noradrenaline overflow and endothelin-1 overproduction

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 4, 2005, Pages 641-645

  Fujii, Toshihide ^a   Takaoka, Masanori ^a   Ohkita, Mamoru ^a   Matsumura, Yasuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Acute renal failure; Endothelin 1; Ischemia; Noradrenaline; Renal sympathetic nerve; Tempol

Indexed keywords

CREATININE; ENDOTHELIN 1; NITROGEN; NORADRENALIN; SODIUM; TEMPOL; UREA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HISTOPATHOLOGY; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY INNERVATION; KIDNEY ISCHEMIA; KIDNEY MEDULLA; KIDNEY TUBULE; KIDNEY TUBULE NECROSIS; KIDNEY VEIN; MALE; NEPHRECTOMY; NONHUMAN; NORADRENALIN BLOOD LEVEL; NORADRENALIN RELEASE; PROTEIN DETERMINATION; PROTEIN SECRETION; RAT; RENAL PROTECTION; REPERFUSION INJURY; SODIUM EXCRETION; SYMPATHETIC NERVE; SYMPATHETIC TONE; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

ANIMALS; CYCLIC N-OXIDES; ENDOTHELIN-1; GENE EXPRESSION; KIDNEY; KIDNEY FAILURE, ACUTE; MALE; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SPIN LABELS;

EID: 21144449508     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.641     Document Type: Article

References (41)

1. Thadhani R., Pascual M., Bonventre J. V., N. Engl. J. Med., 334, 1448-1460 (1996).
2. Lieberthal W., Levine J. S., Am. J. Physiol., 271, F477-F488 (1996).
3. Edelstein C. L., Ling H., Schrier R. W., Kidney Int., 51, 1341-1351 (1997).
4. Baines A. D., Clin. Biochem., 16, 134-140 (1983).
5. Iaina A., Eliahou H. E., Clin. Exp. Dial. Apheresis., 7, 115-125 (1983).
6. Fujii T., Kurata H., Takaoka M., Muraoka T., Fujisawa Y., Shokoji T., Nishiyama A., Abe Y., Matsumura Y., Eur. J. Pharmacol., 481, 241-248 (2003).
7. Iannone A., Bini A., Swartz H. M., Tomasi A., Vannini V., Biochem. Pharmacol., 38, 2581-2586 (1989).
8. Schnackenberg C. G., Wilcox C. S., Hypertension, 33, 424-428 (1999).
9. Chatterjee P. K., Cuzzocrea S., Brown P. A., Zacharowski K., Stewart K. N., Mota-Filipe H., Thiemermann C., Kidney Int., 58, 658-673 (2000).
10. Patel N. S., Chatterjee P. K., Chatterjee B. E., Cuzzocrea S., Serraino I., Brown P. A., Stewart K. N., Mota-Filipe H., Thiemermann C., Free Radic. Biol. Med., 33, 1575-1589 (2002).
11. Touyz R. M., Hypertension, 44, 248-252 (2004).
12. Doi K., Suzuki Y., Nakao A., Fujita T., Noiri E., Kidney Int., 65, 1714-1723 (2004).
13. Xu H., Fink G. D., Galligan J. J., Am. J. Physiol., 283, H885-H892 (2002).
14. Shokoji T., Nishiyama A., Fujisawa Y., Hitomi H., Kiyomoto H., Takahashi N., Kimura S., Kohno M., Abe Y., Hypertension, 41, 266-273 (2003).
15. Shibouta Y., Suzuki N., Shino A., Matsumoto H., Terashita Z., Kondo K., Nishikawa K., Life Sci., 46, 1611-1618 (1990).
16. Wilhelm S. M., Simonson M. S., Robinson A. V., Stowe N. T., Schulak J. A., Kidney Int., 55, 1011-1018 (1999).
17. Kuro T., Kohnou K., Kobayashi Y., Takaoka M., Opgenorth T. J., Wessale J. L., Matsumura Y., Jpn. J. Pharmacol., 82, 307-316 (2000).
18. Hayashi K., Matsumura Y., Yoshida Y., Suzuki Y., Morimoto S., J. Cardiovasc. Pharmacol., 17, 807-813 (1991).
19. Solez K., Kramer E. C., Fox J. A., Heptinstall R. H., Kidney Int., 6, 24-37 (1974).
20. Fujita K., Matsumura Y., Miyazaki Y., Kita S., Hisaki K., Takaoka M., Morimoto S., Br. J. Pharmacol., 114, 925-930 (1995).
21. Matsumura Y., Ikegawa R., Takaoka M., Morimoto S., Biochem. Biophys. Res. Commun., 167, 203-210 (1990).
22. Oliver J. A., Pinto J., Sciacca R. R., Cannon P. J., Am. J. Physiol., 239, F371-F377 (1980).
23. Grace P. A., Br. J. Surg., 81, 637-647 (1994).
24. Weight S. C., Bell P. R., Nicholson M. L., Br. J. Surg., 83, 162-170 (1996).
25. Paller M. S., Hoidal J. R., Ferris T. F., J. Clin. Invest., 74, 1156-1164 (1984).
26. Green C. J., Healing G., Simpkin S., Fuller B. J., Lunec J., Cryobiology, 23, 358-365 (1986).
27. Green C. J., Healing G., Simpkin S., Gower J., Fuller B. J., Free Radic. Res. Commun., 6, 329-337 (1989).
28. Gelvan D., Saltman P., Powell S. R., Proc. Natl. Acad. Sci. U.S.A., 88, 4680-4684 (1991).
29. Schnackenberg C. G., Welch W. J., Wilcox C. S., Hypertension, 32, 59-64 (1998).
30. Karmeli F., Eliakim R., Okon E., Samuni A., Rachmilewitz D., Gut, 37, 386-393 (1995).
31. Mitchel J. B., DeGraff W., Kaufman D., Krishna M. C., Samuni A., Finkelstein E., Ahn M. S., Hahn S. M., Gamson J., Russon A., Arch. Biochem. Biophys., 289, 62-70 (1991).
32. Xu H., Fink G. D., Chen A., Watts S., Galligan J. J., Am. J. Physiol., 281, H975-H980 (2001).
33. Xu H., Fink G. D., Galligan J. J., Hypertension, 43, 329-334 (2004).
34. Gellai M., Jugus M., Fletcher T., Nambi P., Ohlstein E. H., Elliot J. D., Brooks D. P., J. Phamacol. Exp. Ther., 275, 200-206 (1995).
35. Birck P., Knoll T., Braun C., Kirchengast M., Munter K., Van der Woude F. K., Rohmeiss P., J. Cardiovasc. Pharmacol., 32, 80-86 (1998).
36. Kourembanas S., Marsden P. A., McQuillan L. P., Faller D. V., J. Clin. Invest., 88, 1054-1057 (1991).
37. Ong A. C. M., Jowett T. P., Firth J. D., Burton S., Karet F. E., Fine L. G., Kidney Int., 48, 390-401 (1995).
38. Hughes A. K., Stricklett P., Padilla E., Kohan D. E., Kidney Int., 49, 181-189 (1996).
39. Bierhaus A., Chevion S., Chevion M., Hofmann M., Quehenberger P., Illmer T., Luther T., Berentshtein E., Tritschler H., Muller M., Wahl P., Ziegler R., Nawroth P. P. Diabetes, 46, 1481-1490(1997).
40. Ohkita M., Takaoka M., Kobayashi Y., Itoh E., Uemachi H., Matsumura Y., Jpn. J. Pharmacol., 88, 197-205 (2002).
41. Wilhelm S. M., Stowe N. T., Robinson A. V., Schulak J. A., Transplantation, 71, 211-216 (2001).